CUE financials

Cue Biopharma (CUE) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

CUE income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$27.47M–-$26.55M-$26.60M-8.40
2024$9.29M–-$41.50M-$40.67M-21.60
2023$5.49M–-$52.15M-$50.73M-33.30
2022$1.25M–-$53.23M-$53.01M-44.70
2021$14.94M–-$43.71M-$44.16M-42.30
2020$3.15M–-$45.04M-$44.78M-46.80

Updated 2026-11-18 05:48 UTC